Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 228

Similar articles for PubMed (Select 23590389)

2.

Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.

Schuetz P, Müller B, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, Kristoffersen KB, Burkhardt O, Welte T, Schroeder S, Nobre V, Wei L, Bhatnagar N, Bucher HC, Briel M.

Evid Based Child Health. 2013 Jul;8(4):1297-371. doi: 10.1002/ebch.1927. Review.

PMID:
23877944
3.

Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.

Schuetz P, Müller B, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, Kristoffersen KB, Burkhardt O, Welte T, Schroeder S, Nobre V, Wei L, Bhatnagar N, Bucher HC, Briel M.

Cochrane Database Syst Rev. 2012 Sep 12;9:CD007498. doi: 10.1002/14651858.CD007498.pub2. Review.

PMID:
22972110
4.

The Procalcitonin And Survival Study (PASS) - a randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients.

Jensen JU, Lundgren B, Hein L, Mohr T, Petersen PL, Andersen LH, Lauritsen AO, Hougaard S, Mantoni T, Bømler B, Thornberg KJ, Thormar K, Løken J, Steensen M, Carl P, Petersen JA, Tousi H, Søe-Jensen P, Bestle M, Hestad S, Andersen MH, Fjeldborg P, Larsen KM, Rossau C, Thomsen CB, Ostergaard C, Kjaer J, Grarup J, Lundgren JD.

BMC Infect Dis. 2008 Jul 13;8:91. doi: 10.1186/1471-2334-8-91.

5.

Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial.

Schuetz P, Christ-Crain M, Wolbers M, Schild U, Thomann R, Falconnier C, Widmer I, Neidert S, Blum CA, Schönenberger R, Henzen C, Bregenzer T, Hoess C, Krause M, Bucher HC, Zimmerli W, Müller B; ProHOSP study group.

BMC Health Serv Res. 2007 Jul 5;7:102.

7.

Procalcitonin-guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock.

Hohn A, Schroeder S, Gehrt A, Bernhardt K, Bein B, Wegscheider K, Hochreiter M.

BMC Infect Dis. 2013 Apr 1;13:158. doi: 10.1186/1471-2334-13-158.

9.

Effect of procalcitonin-guided treatment in patients with infections: a systematic review and meta-analysis.

Tang H, Huang T, Jing J, Shen H, Cui W.

Infection. 2009 Dec;37(6):497-507. doi: 10.1007/s15010-009-9034-2. Epub 2009 Oct 13. Review.

PMID:
19826761
10.

Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial.

Hochreiter M, Köhler T, Schweiger AM, Keck FS, Bein B, von Spiegel T, Schroeder S.

Crit Care. 2009;13(3):R83. doi: 10.1186/cc7903. Epub 2009 Jun 3.

11.

Procalcitonin-based therapeutic strategy to reduce antibiotic use in patients after cardiac surgery: a randomized controlled trial.

Maravić-Stojković V, Lausević-Vuk L, Jović M, Ranković A, Borzanović M, Marinković J.

Srp Arh Celok Lek. 2011 Nov-Dec;139(11-12):736-42.

PMID:
22338468
12.

Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial.

Stocker M, Fontana M, El Helou S, Wegscheider K, Berger TM.

Neonatology. 2010;97(2):165-74. doi: 10.1159/000241296. Epub 2009 Sep 24.

PMID:
19776651
13.

Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial.

Shehabi Y, Sterba M, Garrett PM, Rachakonda KS, Stephens D, Harrigan P, Walker A, Bailey MJ, Johnson B, Millis D, Ding G, Peake S, Wong H, Thomas J, Smith K, Forbes L, Hardie M, Micallef S, Fraser JF; ProGUARD Study Investigators; ANZICS Clinical Trials Group.

Am J Respir Crit Care Med. 2014 Nov 15;190(10):1102-10. doi: 10.1164/rccm.201408-1483OC.

PMID:
25295709
14.

Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial.

Jensen JU, Hein L, Lundgren B, Bestle MH, Mohr TT, Andersen MH, Thornberg KJ, Løken J, Steensen M, Fox Z, Tousi H, Søe-Jensen P, Lauritsen AØ, Strange D, Petersen PL, Reiter N, Hestad S, Thormar K, Fjeldborg P, Larsen KM, Drenck NE, Ostergaard C, Kjær J, Grarup J, Lundgren JD; Procalcitonin And Survival Study (PASS) Group.

Crit Care Med. 2011 Sep;39(9):2048-58. doi: 10.1097/CCM.0b013e31821e8791.

PMID:
21572328
15.

Clinical and economic impact of procalcitonin to shorten antimicrobial therapy in septic patients with proven bacterial infection in an intensive care setting.

Deliberato RO, Marra AR, Sanches PR, Martino MD, Ferreira CE, Pasternak J, Paes AT, Pinto LM, dos Santos OF, Edmond MB.

Diagn Microbiol Infect Dis. 2013 Jul;76(3):266-71. doi: 10.1016/j.diagmicrobio.2013.03.027. Epub 2013 May 25.

PMID:
23711530
16.

The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?

Sridharan P, Chamberlain RS.

Surg Infect (Larchmt). 2013 Dec;14(6):489-511. doi: 10.1089/sur.2012.028. Epub 2013 Nov 25. Review.

PMID:
24274059
17.

Procalcitonin guided antibiotic therapy of acute exacerbations of asthma: a randomized controlled trial.

Tang J, Long W, Yan L, Zhang Y, Xie J, Lu G, Yang C.

BMC Infect Dis. 2013 Dec 17;13:596. doi: 10.1186/1471-2334-13-596.

18.

A pilot randomised controlled trial in intensive care patients comparing 7 days' treatment with empirical antibiotics with 2 days' treatment for hospital-acquired infection of unknown origin.

Scawn N, Saul D, Pathak D, Matata B, Kemp I, Stables R, Lane S, Haycox A, Houten R.

Health Technol Assess. 2012 Sep;16(36):i-xiii, 1-70.

19.
20.

Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.

Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, Schortgen F, Lasocki S, Veber B, Dehoux M, Bernard M, Pasquet B, Régnier B, Brun-Buisson C, Chastre J, Wolff M; PRORATA trial group.

Lancet. 2010 Feb 6;375(9713):463-74. doi: 10.1016/S0140-6736(09)61879-1. Epub 2010 Jan 25.

PMID:
20097417
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk